Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Linking erectile dysfunction and coronary artery disease

Abstract

Coronary artery disease (CAD) and erectile dysfunction (ED) are both highly prevalent conditions that frequently coexist. Additionally, they share mutual vascular risk factors, suggesting that they are both manifestations of systemic vascular disease. The role of endothelial dysfunction in CAD is well established. Normal erectile function is primarily a vascular event that relies heavily on endothelially derived, nitric oxide-induced vasodilation. Accordingly, endothelial dysfunction appears to be a common pathological etiology and mechanism of disease progression between CAD and ED. The risk factors of diabetes mellitus, hypertension, hyperlipidemia, obesity and tobacco abuse contribute to endothelial dysfunction. This article reviews the role of vascular endothelium in health, the abnormalities resulting from vascular risk factors, and clinical trials evaluating the role of endothelial dysfunction in ED.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Purchase on Springer Link

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Montorsi P et al. Common grounds for erectile dysfunction and coronary artery disease. Curr Opinion Urol 2004; 14: 361–365.

    Google Scholar 

  2. Gazzaruso C et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004; 110: 22–26.

    PubMed  Google Scholar 

  3. Virag R, Bouilly P, Frydman D . Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 1: 181–184.

    CAS  PubMed  Google Scholar 

  4. Fung MM, Bettencourt R, Barrett-Connor E . Heart disease risk factors predict erectile dysfunction 25 years later: The Rancho Bernardo Study. J Am Coll Cardiol 2004; 43: 1405–1411.

    Article  PubMed  Google Scholar 

  5. Roose SP . Depression: links with ischemic heart disease and erectile dysfunction. J Clin Psychiatry. 2003; 64: 26–30.

    PubMed  Google Scholar 

  6. Tan RS, Pu SJ . The interlinked depression, erectile dysfunction and coronary heart disease syndrome in older men: a triad often underdiagnosed. J Gend Specif Med 2003; 6: 31–36.

    PubMed  Google Scholar 

  7. Solomon H, Man JW, Wierzbicki AS, Jackson G . Relation of erectile dysfunction to angiographic artery disease. Am J Cardiol 2003; 91: 230–231.

    PubMed  Google Scholar 

  8. Greenstein A et al. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997; 9: 123–126.

    CAS  PubMed  Google Scholar 

  9. Montorsi F et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003; 44: 360–364.

    PubMed  Google Scholar 

  10. Shamloul R et al. Correlation between penile duplex findings and stress electrocardiography in men with erectile dysfunction. Int J Impot Res 2004; 16: 235–237.

    CAS  PubMed  Google Scholar 

  11. Blumentals WA, Gomez-Caminero A, Joo S, Vannappagari V . Is erectile dysfunction predictive of peripheral vascular disease? Aging Male 2003; 6: 217–221.

    CAS  PubMed  Google Scholar 

  12. Blumentals WA, Gomez-Caminero A, Joo S, Vannappagari V . Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results of a retrospective cohort study. Int J Impot Res 2004; 16: 350–353.

    CAS  PubMed  Google Scholar 

  13. Kirby M, Jackson G, Simonsen U . Endothelial dysfunction links erectile dysfunction to heart disease. Int J Clin Pract 2005; 59: 225–229.

    CAS  PubMed  Google Scholar 

  14. Schachinger V, Zeiher AM . Prognostic implications of endothelial dysfunction: does it mean anything? Coronary Artery Dis 2001; 12: 435–443.

    CAS  Google Scholar 

  15. Brunner H et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23: 233–246.

    CAS  PubMed  Google Scholar 

  16. Andersson K, Stief C . Penile erection and cardiac risk: pathophysiologic and pharmacologic mechanisms. Am J Caridol 2000; 86: 23f–26f.

    CAS  Google Scholar 

  17. Kloner RA, Zusman RM . Cardiovascular effects of sildenafil citrate and recommendations for its use. Am J Cardiol 1999; 84: 11n–17n.

    CAS  PubMed  Google Scholar 

  18. Jeremy JY et al. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cGMP and cAMP levels in the rabbit corpus cavernosum in vitro. Br J Urol 1997; 79: 958–963.

    CAS  PubMed  Google Scholar 

  19. Yavuzgil O et al. Endothelial function in patients with vasculogenic erectile dysfunction. Int J Cardiol 2005; 103: 19–26.

    PubMed  Google Scholar 

  20. Kaiser DR et al. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004; 43: 179–184.

    PubMed  Google Scholar 

  21. Kharbanda RK, Deanfield JE . Functions of the healthy endothelium. Coron Artery Dis 2001; 12: 485–491.

    CAS  PubMed  Google Scholar 

  22. Sagripanti A, Carpi A . Antithrombotic and prothrombotic activities of the vascular endothelium. Biomed Pharmacother 2000; 54: 107–111.

    CAS  PubMed  Google Scholar 

  23. Panes J, Perry M, Granger DN . Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention. Br J Pharmacol 1999; 126: 537–550.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Mombouli J, Vanhoutte PM . Endothelial dysfunction: from physiology to therapy. J Mol Cell Cardiol 1999; 31: 61–74.

    CAS  PubMed  Google Scholar 

  25. Fleming I, Busse R . Control and consequences of endothelial nitric oxide formation. Adv Pharmacol 1995; 34: 187–206.

    CAS  PubMed  Google Scholar 

  26. Duffy SJ et al. Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans. Am J Physiol 1998; 274: H1174–H1183.

    CAS  PubMed  Google Scholar 

  27. Ross R . The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–809.

    CAS  PubMed  Google Scholar 

  28. Russell S, Nehra A . The physiology of erectile dysfunction. Herz 2003; 28: 277–283.

    PubMed  Google Scholar 

  29. Saenz de Tejada I et al. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989; 320: 1025–1030.

    CAS  PubMed  Google Scholar 

  30. Escrig A et al. Changes in mating behavior, erectile function, and nitric oxide levels in penile corpora cavernosa in streptozotocin-diabetic rats. Biol Reprod 2002; 66: 185–189.

    CAS  PubMed  Google Scholar 

  31. Vallance P, Chan N . Endothelial function and nitric oxide: clinical relevance. Heart 2001; 85: 342–350.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Leiper JM et al. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deaminases. Biochem J 1999; 343: 209–214.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Seftel AD et al. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition and possible effect through iNOS or eNOS. Urology 1997; 50: 1016–1026.

    CAS  PubMed  Google Scholar 

  34. Cartledge JJ, Eardley I, Morrison JF . Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes. BJU Int 2001; 87: 402–407.

    CAS  PubMed  Google Scholar 

  35. Jevtich MJ, Edson M, Jarman WD, Herrera HH . Vascular factor in erectile failure among diabetics. Urology 1982; 19: 163–168.

    CAS  PubMed  Google Scholar 

  36. Francavilla S et al. Endothelin-1 in diabetic and non-diabetic men with erectile dysfunction. J Urol 1997; 158: 1770–1774.

    CAS  PubMed  Google Scholar 

  37. Bell CR et al. The density and distribution of endothelin 1 and endothelin receptor subtypes in normal and diabetic rat corpus cavernosum. Br J Urol 1995; 76: 203–207.

    CAS  PubMed  Google Scholar 

  38. Becker AJ et al. Systemic and cavernosal plasma levels of endothelin (1–21) during different penile conditions in healthy males and patients with erectile dysfunction. World J Urol 2001; 19: 371–376.

    CAS  PubMed  Google Scholar 

  39. Takahashi K et al. Elevated plasma endothelin in patients with diabetes mellitus. Diabetalogia 1990; 33: 306–310.

    CAS  Google Scholar 

  40. Dogra G, Rich L, Stanton K, Watts GF . Endothelium-dependent and -independent vasodilation studies at normoglycaemia in type 1 diabetes mellitus with and without microalbuminuria. Diabetologia 2001; 44: 593–601.

    CAS  PubMed  Google Scholar 

  41. Elliott TG et al. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 1993; 85: 687–693.

    CAS  Google Scholar 

  42. Chowienczyk PJ et al. Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type 2 diabetes. Diabetologia 2000; 43: 974–977.

    CAS  PubMed  Google Scholar 

  43. Jacobs M, Plane F, Bruckdorfer KR . Native and oxidized low-density-lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta. Br J Pharmacol 1990; 100: 21–26.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Head RJ . Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of spontaneously hypertensive rat. Blood Vessels 1989; 26: 1–20.

    CAS  PubMed  Google Scholar 

  45. Bemelmans BL et al. Erectile dysfunction in diabetic men: the neurological factor revisited. J Urol 1994; 151: 884–889.

    CAS  PubMed  Google Scholar 

  46. Blanco R et al. Dysfunctional penile cholinergic nerves in diabetic impotent men. J Urol 1999; 144: 278–280.

    Google Scholar 

  47. Melman A, Bressler RS, Henry DP, Macadoo VK . Ultrastructure of human penile erectile tissues in patients with abnormal norepinephrine content. Invest Urol 1981; 19: 46–48.

    CAS  PubMed  Google Scholar 

  48. Panza JA, Quyyumi AA, Brush Jr JE, Epstein SE . Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22–27.

    CAS  PubMed  Google Scholar 

  49. Koga T et al. Age and hypertension promote endothelium-dependent contractions to acetylcholine in the aorta of the rat. Hypertension 1989; 14: 542–548.

    CAS  PubMed  Google Scholar 

  50. Kung CF, Luscher TF . Different mechanisms of endothelial dysfunction with aging and hypertension in the rabbit aorta. Hypertension 1995; 25: 194–200.

    CAS  PubMed  Google Scholar 

  51. Nakayama M et al. T-786-C mutation in the 5′flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864–2870.

    CAS  PubMed  Google Scholar 

  52. Rossi GP et al. The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol 2003; 41: 938–945.

    CAS  PubMed  Google Scholar 

  53. Taddei S et al. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 1997; 29: 274–279.

    CAS  PubMed  Google Scholar 

  54. Behr-Roussel D et al. Erectile dysfunction in spontaneously hypertensive rats: pathophysiological mechanisms. Am J Physiol Regul Integr Comp Physiol 2003; 284: R682–R688.

    CAS  PubMed  Google Scholar 

  55. Calver A, Collier J, Moncada S, Vallance P . Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: nitric oxide dilator mechanism appears abnormal. J Hypertens 1992; 10: 1025–1031.

    CAS  PubMed  Google Scholar 

  56. Folkow B . Structural factor' in primary and secondary hypertension. Hypertension 1990; 16: 89–101.

    CAS  PubMed  Google Scholar 

  57. Toblli JE et al. Morphological changes in cavernous tissue in spontaneously hypertensive rats. Am J Hypertens 2000; 13: 686–692.

    CAS  PubMed  Google Scholar 

  58. Quyyumi AA et al. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P. Circulation 1997; 95: 104–110.

    CAS  PubMed  Google Scholar 

  59. Kuvin JT et al. A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression. Am Heart J 2002; 144: 165–172.

    CAS  PubMed  Google Scholar 

  60. Lupattelli G et al. Direct association between high-density lipoprotein cholesterol and endothelial function in hyperlipemia. Am J Cardiol 2002; 90: 648–650.

    CAS  PubMed  Google Scholar 

  61. Spieker LE et al. High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation 2002; 105: 1399–1402.

    CAS  PubMed  Google Scholar 

  62. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW . C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vas Biol 1999; 19: 972–978.

    CAS  Google Scholar 

  63. Ziccardi P et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804–809.

    CAS  PubMed  Google Scholar 

  64. Bhagat K, Vallance P . Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 1997; 96: 3042–3047.

    CAS  PubMed  Google Scholar 

  65. Giugliano D et al. L-arginine for testing endothelium-dependent vascular functions in health and disease. Am J Physiol 1997; 273: E606–E612.

    CAS  PubMed  Google Scholar 

  66. Perticone F et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes 2001; 50: 159–165.

    CAS  PubMed  Google Scholar 

  67. Mather KJ et al. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes 2002; 51: 3517–3523.

    CAS  PubMed  Google Scholar 

  68. Suwaidi JA et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948–954.

    CAS  PubMed  Google Scholar 

  69. Schachinger V, Zeiher AM . Quantitative assessment of coronary vasoreactivity in humans in vivo: importance of baseline vasomotor tone in atherosclerosis. Circulation 1995; 92: 2087–2094.

    CAS  PubMed  Google Scholar 

  70. Schachinger V, Britten MB, Zeiher AM . Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899–1906.

    CAS  PubMed  Google Scholar 

  71. Hermann M, Berger P . Hormonal changes in aging men: a therapeutic indication? Exp Gerontol 2001; 36: 1075–1082.

    CAS  PubMed  Google Scholar 

  72. Aversa A et al. Hormonal supplementation and erectile dysfunction. Euro Urol 2005; 47: 564.

    Google Scholar 

  73. Huang X, Li S, Hu L . Growth hormone deficiency and age-related erectile dysfunction. Zhonghus Nan Ke Xue 2004; 10: 867–869.

    CAS  Google Scholar 

  74. Li S, Hu L, Zhao J . Effect of growth hormone on erectile function and number of nNOS-containing verve fibers in internal iliac arterial ligation rats. Zhonghua Nan Ke Xue 2004; 10: 103–106.

    CAS  PubMed  Google Scholar 

  75. Becker AJ et al. Growth hormone, somatomedins and men's health. Aging Male 2002; 5: 258–262.

    CAS  PubMed  Google Scholar 

  76. Bivalacqua TJ et al. Gene therapy techniques for the delivery of endothelial nitric oxide synthase to the corpa cavernosa for erectile dysfunction. Methods Mol Biol 2004; 279: 173–185.

    CAS  PubMed  Google Scholar 

  77. Bivalacqua TJ et al. Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats. Int J Impot Res 2004; 16: 21–29.

    CAS  PubMed  Google Scholar 

  78. Bivalacqua TJ et al. Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol 2003; 169: 1911–1917.

    CAS  PubMed  Google Scholar 

  79. Akinba AG, Burnett AL . Endothelial nitric oxide synthase protein expression, localization, and activity in the penis of the alloxan-induced diabetic rat. Mol Urol 2001; 5: 189–197.

    Google Scholar 

  80. Champion HC et al. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Pharmacology 1999; 96: 11648–11652.

    CAS  Google Scholar 

  81. Tirney S et al. Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid, adenovirus, and adeno virus-transduced myoblast vectors. Mol Urol 2001; 5: 37–43.

    CAS  PubMed  Google Scholar 

  82. Archer SL . Potassium channels and erectile dysfunction. Vascul Pharmacol 2002; 38: 61–71.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E R Schwarz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rodriguez, J., Al Dashti, R. & Schwarz, E. Linking erectile dysfunction and coronary artery disease. Int J Impot Res 17 (Suppl 1), S12–S18 (2005). https://doi.org/10.1038/sj.ijir.3901424

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901424

Keywords

This article is cited by

Search

Quick links